BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Carbamoyl-Phosphate Synthase I Deficiency Disease

Below is an extended Carbamoyl-Phosphate Synthase I Deficiency Disease research listing. Click here to return to the Carbamoyl-Phosphate Synthase I Deficiency Disease main in depth entry.

Recent Publications on Carbamoyl-Phosphate Synthase I Deficiency Disease:

High-volume continuous venovenous hemofiltration as an effective therapy for acute management of inborn errors of metabolism in young children.
BACKGROUND/AIM: Renal replacement therapies (RRTs) have been used for the...
Direct Link
16th October, 2007
Division of Pediatric Nephrology, Department of Pediatrics, National
Molecular and clinical analyses of Japanese patients with carbamoylphosphate synthetase 1 (CPS1) deficiency.
Carbamoylphosphate synthetase I deficiency (CPS1D) is a urea-cycle...
Direct Link
4th July, 2007
Department of Pediatrics, Kyoto University Hospital, 54 Shogoin Sakyo,
Survival after treatment with phenylacetate and benzoate for urea-cycle disorders.
BACKGROUND: The combination of intravenous sodium phenylacetate and sodium...
Direct Link
6th June, 2007
Department of Pediatrics, Division of Medical Genetics, Stanford
The frequent observation of evidence for nonsense-mediated decay in RNA from patients with carbamyl phosphate synthetase I deficiency.
CPSI deficiency is an inborn error of metabolism caused by mutations in...
Direct Link
1st November, 2006
Vanderbilt University, Center for Human Genetic Research, Department of
Carbamyl phosphate synthase deficiency: diagnosed during pregnancy in a 41-year-old.
Carbamyl phosphate synthase deficiency (CPS) is a rare urea cycle defect....
Direct Link
4th October, 2006
Department of Neurology, The Royal Brisbane Hospital, Brisbane, Australia.
Genetic counseling issues in urea cycle disorders.
The goal of counseling families that have a urea cycle disorder (UCD) is...
Direct Link
27th January, 2006
Department of Pediatrics, Division of Genetics and Development, University
Unmasked adult-onset urea cycle disorders in the critical care setting.
Most often, urea cycle disorders have been described as acute onset...
Direct Link
27th January, 2006
Center for Human Genetic Research, Division of Medical Genetics,
Viral infections and prolonged fever after liver transplantation in young children with inborn errors of metabolism. 21st December, 2005
Department of Pediatrics, National Taiwan University Hospital and National
Understanding carbamoyl phosphate synthetase deficiency: impact of clinical mutations on enzyme functionality.
Carbamoyl phosphate synthetase I (CPSI) deficiency, a recessively...
Direct Link
23rd June, 2005
Centro de Investigacion Principe Felipe, FVIB, Avda. Autopisca del Saler,
Mutational analysis of carbamoylphosphate synthetase I deficiency in three Japanese patients. 6th May, 2005
Department of Neurology, Institute of Neurological Sciences, Tottori
Brain glutamine by MRS in a patient with urea cycle disorder and coma.
In patients who undergo metabolic decompensation from urea cycle...
Direct Link
29th April, 2005
Department of Pediatrics, the University of Michigan School of Medicine,
Environmentally determined genetic expression: clinical correlates with molecular variants of carbamyl phosphate synthetase I.
Carbamyl phosphate synthetase I (CPSI) determines the rate-limiting entry...
Direct Link
17th February, 2005
Division of Medical Genetics, Department of Pediatrics and Molecular
Developmental outcomes with early orthotopic liver transplantation for infants with neonatal-onset urea cycle defects and a female patient with late-onset ornithine transcarbamylase deficiency.
Urea cycle defects (UCDs) typically present with hyperammonemia, the...
Direct Link
16th February, 2005
Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas,
Interstitial deletion of chromosome 2q32-34 associated with multiple congenital anomalies and a urea cycle defect (CPS I deficiency).
A de novo deletion of the long arm of chromosome 2 at 2q31-33 was observed...
Direct Link
26th January, 2005
Department of Pediatrics, Johns Hopkins University, Baltimore, MD, USA.
Clinical consequences of urea cycle enzyme deficiencies and potential links to arginine and nitric oxide metabolism. 16th December, 2004
Department of Molecular and Human Genetics, Children's Nutritional
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional